Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.25%
1,110.47
+13.75
+1.25%
1,096.721,098.741,113.821,098.74
SIXC
Communications
SIXC
Communications
SIXC
-1.19%
604.07
-7.25
-1.19%
611.32611.32611.32603.33
SIXE
Energy
SIXE
Energy
SIXE
+2.56%
1,201.49
+29.95
+2.56%
1,171.541,176.151,202.381,176.15
SIXI
Industrials
SIXI
Industrials
SIXI
+1.01%
1,765.30
+17.67
+1.01%
1,747.631,747.671,770.511,744.43
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
630.42
-1.07
-0.17%
631.49631.23633.90627.95
SIXR
Staples
SIXR
Staples
SIXR
-1.00%
841.45
-8.49
-1.00%
849.94850.23850.23836.20
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.35%
218.83
+0.77
+0.35%
218.06218.06219.96218.02
SIXT
Technology
SIXT
Technology
SIXT
+1.31%
3,582.23
+46.20
+1.31%
3,536.033,549.423,590.523,543.38
SIXU
Utilities
SIXU
Utilities
SIXU
+0.97%
913.89
+8.82
+0.97%
905.07908.07916.83907.68
SIXV
Health care
SIXV
Health care
SIXV
-0.38%
1,444.33
-5.53
-0.38%
1,449.861,451.341,464.451,440.75
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,412.96
-17.51
-0.72%
2,430.472,415.842,422.952,396.14
ACRS:NASDAQ
Aclaris Therapeutics Inc
$4.95
0.00%
(0.00) 1D
$5.04
+1.82% (+0.090)
Pre-market
Closed: May 11, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACRS...
Mkt. cap
691.33M
Avg. vol.
1.38M
Volume
3.96K
52-wk high
$5.12
52-wk low
$1.16
EPS
-$0.56
Beta
0.77
Shares outstanding
139.66M
No. of employees
71
News stories
From sources across the web
About Aclaris Therapeutics Inc
CEO-
Employees71
Founded2012
Headquarters-
SectorPharmaceutical industry
Last report
May 7, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.15 / -$0.16
+3.67%beat
Revenue / Est. (USD)
2.00M / 1.32M
+51.02%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.78M
3.30M
1.30M
2.00M
Cost of goods sold
13.30M
15.48M
18.05M
17.44M
Cost of revenue
13.30M
15.48M
18.05M
17.44M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.39M
4.87M
5.58M
6.74M
Operating expense
5.39M
4.87M
5.58M
6.74M
Total operating expenses
18.68M
20.35M
23.63M
24.19M
Operating income
-16.91M
-17.05M
-22.33M
-22.19M
Other non operating income
961.00K
716.00K
1.30M
854.00K
EBT including unusual items
-15.43M
-14.61M
-19.80M
-19.82M
EBT excluding unusual items
-13.93M
-14.51M
-19.40M
-19.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15.43M
-14.61M
-19.80M
-19.82M
Net profit margin
-868.26%
-442.98%
-1,528.57%
-993.19%
Earnings per share
-0.13
-0.12
-0.16
-0.15
Interest and investment income
2.02M
1.82M
1.63M
1.51M
Interest expense
-
-
-
-
Net interest expenses
2.02M
1.82M
1.63M
1.51M
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.88M
-17.04M
-22.32M
-22.19M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more